Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid administration methods in total hip arthroplasty
ChiCTR2600128882Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in hip osteoarthritis, osteonecrosis of the hip and hip dysplasia (DDH) (3 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Total blood loss. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
hip osteoarthritisosteonecrosis of the hiphip dysplasia (DDH)
Beyond the preview
Go deeper on ChiCTR2600128882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128882.